基于膀性口腔炎病毒的解性病毒疗法:最近的进展和新兴趋势
Cassandra Catacalos-Goad1, Charlotte Johnstone1, Valery Z Grdzelishvili1
1Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
Current oncology (Toronto, Ont.)
|November 26, 2025
概括
膀性口腔炎病毒 (VSV) 通过选择性地破坏瘤细胞并促进免疫反应,在癌症治疗中表现有前途. 目前正在进行的研究重点是提高VSV的安全性和有效性,以获得更广泛的临床应用.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤解毒性病毒疗法利用病毒选择性地向和破坏癌细胞,刺激抗瘤免疫力.
- 膀性口腔炎病毒 (VSV) 是一个成熟的瘤性病毒平台,由于其快速复制,细胞溶解能力和遗传操纵性.
- 在人类中,VSV表现出缺乏先前存在的免疫力,这使其成为治疗干预的合适候选人.
研究的目的:
- 自上次审查以来,提供关于基于VSV的性病毒疗法的进展的全面更新.
- 要突出安全性,瘤选择性,瘤特异复制,直接瘤溶解和诱导抗瘤免疫力的改进.
- 探索新兴的拉布病毒 (Maraba,Morreton和Jurona) 作为潜在的瘤治疗平台.
主要方法:
- 文献综述VSV基于性病毒疗法的最新发展.
- 对VSV和相关的狂犬病毒进行临床前和临床研究的分析.
- 应用发现与基础知识的整合.
主要成果:
- 在提高VSV作为瘤治疗病毒的安全性和有效性方面取得了重大进展.
- 在瘤选择性和瘤特异复制方面取得了改进.
- 已经观察到VSV对抗瘤免疫反应的强化诱导.
结论:
- 基于VSV的结性病毒疗法正在向更广泛的临床转化迈进.
- 进一步的研究将最近的发现与现有知识相结合,将改善患者的治疗结果.
- 相关的拉布多病毒为型病毒疗法提供了有前途的替代平台.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Cancer Vaccines
936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Subviral Agents
485
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
485


